Stock & Company Details
Immunic Inc $IMUX
Price:
N/A
N/A
14M
$109M
52 Week High:
N/A
10 Day Average Volume:
N/A
-1.44
50 Day Moving Average:
N/A
52 Week Low:
N/A
30 Day Average Volume:
N/A
N/A
N/A
N/A
30 Day Change:
N/A
3 Month Change:
N/A
Health Technology
IMUX technical indicators
Latest Immunic Inc (IMUX) indicator readings as of 2026-10-29.
IMUX's 14-day RSI is 43.2, in neutral territory. At $7.79 it is trading 7.7% below its 200-day moving average of $8.44, and below its 50-day average of $10.42. Price sits in the middle of its Bollinger Bands ($6.65 to $8.35). ADX reads 30.0, indicating a trending market.
Overview
Immunic Inc is a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases, including ulcerative colitis, Crohn's disease, relapsing-remitting multiple sclerosis, and psoriasis. The company is developing three small molecule products, which include IMU-838, which is a selective immune modulator that inhibits the intracellular metabolism of activated immune cells by blocking the enzyme DHODH; IMU-935 is an inverse agonist of RORyt, and IMU-856 targets the restoration of the intestinal barrier function.
Finance Bot
Ask your questions
Start by typing a question below.
